ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

NCI to set separate payline for R01s over $700,000.

February 13, 2004

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Obama Signs Spending Bill for FY09

March 13, 2009

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990